BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6196538)

  • 21. The role of V antigen in mice experimentally infected with Yersinia pseudotuberculosis; histopathological study using enzyme immunoassay.
    Sugiyama Y; Kaneko K; Takashima I; Hashimoto N
    Nihon Juigaku Zasshi; 1986 Aug; 48(4):781-9. PubMed ID: 3531653
    [No Abstract]   [Full Text] [Related]  

  • 22. The first successful isolation and identification of Yersinia pseudotuberculosis serogroup IIA in Japan.
    Tsubokura M; Otsuki K; Kawaoka Y; Hongo T; Otani H; Kishida K; Tanaka M; Sato K
    Microbiol Immunol; 1982; 26(12):1187-8. PubMed ID: 6763137
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pseudotuberculosis].
    Koroliuk AM; Tokarevich KN
    Tr Inst Im Pastera; 1976; 46():48-66. PubMed ID: 801304
    [No Abstract]   [Full Text] [Related]  

  • 24. [The clinico-allergic indices of yersiniosis patients].
    Rashidova RA; Babakhodzhaev SN; Mukhamedov IB
    Ter Arkh; 1991; 63(11):33-5. PubMed ID: 1810058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune stratum of the population in relation to the causative agent of pseudotuberculosis].
    Pichugin SV
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):34-6. PubMed ID: 3318228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Yersinia enteritis].
    Sakamoto M; Sagara H
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):493-5. PubMed ID: 10088454
    [No Abstract]   [Full Text] [Related]  

  • 27. [The function of the body phagocytic system in yersiniosis and the possibilities for correcting its disorders].
    Shuvalova EP; Krotkova MR; Ivashchenko VD
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):82-3. PubMed ID: 8079586
    [No Abstract]   [Full Text] [Related]  

  • 28. Different histologic types of mesenteric lymphadenitis in Yersinia pseudotuberculosis type I and type II infection.
    Böhm N; Wybitul K
    Pathol Res Pract; 1978 Jul; 162(3):301-15. PubMed ID: 356012
    [No Abstract]   [Full Text] [Related]  

  • 29. [PLP test as a rapid method for preliminary identification of Yersinia enterocolica and Yersinia pseudotuberculosis].
    Zaremba M
    Med Dosw Mikrobiol; 1978; 30(4):243-6. PubMed ID: 35722
    [No Abstract]   [Full Text] [Related]  

  • 30. [Structural changes in the kidneys during experimental infection caused by Yersinia pseudotuberculosis].
    Isachkova LM; Zhavoronkov AA; Karbysheva NV; Ponomarev BL
    Biull Eksp Biol Med; 1986 Jul; 102(7):109-12. PubMed ID: 3524703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunoglobulins and their specific activity in Far Eastern scarlatina-like fever].
    Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Apr; (4):101-2. PubMed ID: 7023139
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of pseudotuberculosis coagglutinating antibody diagnostic agent in laboratory practice].
    Tseneva GIa; Kuliashova LB; Belaia IuA; Bystrova SM
    Lab Delo; 1985; (2):111-3. PubMed ID: 2581018
    [No Abstract]   [Full Text] [Related]  

  • 33. Putative origin of Yersinia enterocolitica and Yersinia pseudotuberculosis in Japan.
    Fukushima H; Gomyoda M
    Contrib Microbiol Immunol; 1995; 13():67-70. PubMed ID: 8833799
    [No Abstract]   [Full Text] [Related]  

  • 34. Reiter's disease and Yersinia pseudotuberculosis infection.
    Pennec Y; Mottier D; Youinou P; Le Menn G
    J Rheumatol; 1981; 8(5):868-9. PubMed ID: 7031244
    [No Abstract]   [Full Text] [Related]  

  • 35. [Phagocytic activity of leukocytes in the blood of patients with Far-Eastern scarlatina-like fever].
    Besednova NN; Volodina VN
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):140-2. PubMed ID: 797187
    [No Abstract]   [Full Text] [Related]  

  • 36. [Molecular genetic monitoring of Yersinia pseudotuberculosis using PCR O-genotyping].
    Klimov VT; Chesnokova MV
    Mol Gen Mikrobiol Virusol; 2007; (4):14-7. PubMed ID: 18154076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of lipopolysaccharide of the pseudotuberculosis bacterium on the functional activity of macrophages].
    Kuznetsova TA; Kovalevskaia AM; Sanina OP; Besednova NN
    Antibiot Med Biotekhnol; 1985 Feb; 30(2):109-13. PubMed ID: 3890720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A finding of Yersinia pseudotuberculosis in well water.
    Aldova E; Brezínová A; Sobotková J
    Zentralbl Bakteriol B; 1979 Oct; 169(3-4):265-70. PubMed ID: 396742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation.
    Tansini A; de Medeiros BM
    Scand J Immunol; 2009 Apr; 69(4):310-8. PubMed ID: 19284495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of antibodies in protection from pseudotuberculous infection and intoxication].
    Koroliuk AM
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):97-9. PubMed ID: 358704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.